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Abstract
MicroRNAs play a critical role in many essential cellular functions in the mammalian species. However, limited information is
available regarding the regulation of miRNAs gene transcription. Microarray profiling and real-time PCR analysis revealed a
marked down-regulation of miR-206 in nuclear receptor SHP
2/2 mice. To understand the regulatory function of SHP with
regard to miR-206 gene expression, we determined the putative transcriptional initiation site of miR-206 and also its full
length primary transcript using a database mining approach and RACE. We identified the transcription factor AP1 binding
sites on the miR-206 promoter and further showed that AP1 (c-Jun and c-Fos) induced miR-206 promoter transactivity and
expression which was repressed by YY1. ChIP analysis confirmed the physical association of AP1 (c-Jun) and YY1 with the
endogenous miR-206 promoter. In addition, we also identified nuclear receptor ERRc (NR3B3) binding site on the YY1
promoter and showed that YY1 promoter was transactivated by ERRc, which was inhibited by SHP (NROB2). ChIP analysis
confirmed the ERRc binding to the YY1 promoter. Forced expression of SHP and AP1 induced miR-206 expression while
overexpression of ERRc and YY1 reduced its expression. The effects of AP1, ERRc, and YY1 on miR-206 expression were
reversed by siRNA knockdown of each gene, respectively. Thus, we propose a novel cascade ‘‘dual inhibitory’’ mechanism
governing miR-206 gene transcription by SHP: SHP inhibition of ERRc led to decreased YY1 expression and the de-
repression of YY1 on AP1 activity, ultimately leading to the activation of miR-206. This is the first report to elucidate a
cascade regulatory mechanism governing miRNAs gene transcription.
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Introduction
Small heterodimer partner (SHP, NROB2) is a well established
nuclear transcriptional co-repressor. SHP interacts with a broad
range of nuclear receptors and transcription factors and inhibits
their transactivation [1]. In the past years, the metabolic regulatory
function of SHP has been characterized using SHP
2/2 mice [2–4].
These studies revealed a diverse role of SHP in several metabolic
diseases. Our recent study suggests a new aspect of SHP regulation
in the development of hepatocellular carcinoma (HCC), which is
associated with SHP inhibition of cellular proliferation and
activation of apoptosis signaling [5,6].
MicroRNAs (miRNAs, miR) are highly conserved small RNA
molecules of 22 nucleotides in length which regulate the gene
expression by binding to the 39-untranslated regions (39-UTR) of
specific mRNAs [7]. Despite the growing evidence for their
importance in development, proliferation, and differentiation [8–
10], limited information is available about how miRNAs are
regulated transcriptionally. To determine the regulation of SHP in
miRNAs expression and function, we recently cloned two
overlapping primary transcripts encoding miR-433 and miR-
127, respectively [11]. The coupled miR-433 and miR-127 were
transcribed from independent promoters repressed by SHP in a
compact space by using overlapping genomic regions [12]. Our
study identified SHP as an important transcriptional regulator of
miRNAs gene expression.
In this study, we cloned the full length primary transcript of miR-
206 and elucidated a regulatory cascade activating miR-206
expression by SHPwhich involved AP1 (transcription factor activator
protein 1), YY1 (Ying Yang 1), and ERRc (estrogen related receptor
gamma). This is the first report to elucidate a cascade regulatory
mechanism governing miRNAs gene transcription.
Results
Identifying decreased expression of miR-206 in SHP
2/2
mice and determining miR-206 full length primary
transcript
A custom microarray identified a subset of miRNAs that were
differentially down-regulated in livers of SHP
2/2 mice, which
exhibited a 2-fold or greater decrease in expression (Figure 1a).
Two clusters of miRNAs, miR-206/miR-133b on chromosome 1
and miR-1/miR-133a on chromosome 2 showed the largest
magnitude of down-regulation (Table S1). Interestingly, a cluster
of other down-regulated miRNAs was observed on chromosome 1
(Table S2), which were more distantly located (Figure 1b). Real-
time PCR analysis confirmed that the expression level of miR-206
and miR-133b was decreased by an average of 50% to 60% in the
liver of SHP
2/2 mice than in wild-type (WT) controls (Figure 1c).
Interestingly, the basal expression of miR-206 was about 2-fold
higher than miR-133b, suggesting that the paired miR-206 and
miR-133b might be derived from two primary transcripts under
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433 and miR-127 [11,12]. It was noted that the extent of miR-206
down-regulation was higher by microarray than by real-time PCR.
However, real-time PCR was generally considered as a more
quantitative method for gene expression analysis. Nevertheless,
both methods produced similar expression profiles for miR-206
and showed decreased expression of miR-206 in SHP
2/2 mice.
The down-regulation of these miRNAs in SHP
2/2 mice suggested
that they were potential transcriptional targets of SHP.
We focused on determining the primary transcript encoding
miR-206 because the basal level of miR-206 in the liver was much
higher than miR-133b (Table S1). For this we used a bioinfor-
matics approach developed in our laboratory [11]. Expressed
sequence tag (EST) and non-coding RNA database (mouse non-
RefSeq RNA database from NCBI) analysis identified an EST
sequence (AK031267, GenBank Accession number) ended before
pre-miR-133b (Figure 2–2, T in red), which was followed by the
consensus polyadenylation signal. This suggested that the 39-end of
this EST was complete. The 59-end of this EST ended close to the
39-end of the miR-206 hairpin sequences and did not contain
miR-206, based on the genomic location of pre-miR-206
(Figure 1d). This suggested that it did not contain the full length
pri-miR-206. Sequence prediction suggested that miR-206 and
miR-133b may arise from two separate, and possibly overlapping
primary transcripts. This prediction is consistent with the report
that pri-miRNA transcripts vary in length from a few hundreds of
bases up to tens of kilobases [13]. To elucidate the transcriptional
initiation site (TIS) of the primary transcript of miR-206 (pri-miR-
206), we used Rapid Amplification of cDNA Ends (RACE) to
determine the 59-end of the transcript. 59RACE produced one
strong and two weak PCR products (Figure S1a). However, a
single TIS from the strongest PCR product was confirmed to be
specific by sequencing analysis, which was located 498 nt upstream
of pre-miR-206 (Figure 1d, Figure S1b, and Figure 2–1). The two
weak bands appeared to be non-specific PCR amplification. In
addition, the expression level of pri-miR-206, as detected using
primers in the 59RACE amplified region, was about 50% lower in
SHP
2/2 mice as compared to the wild-type (WT) mice (Figure 1e),
Figure 1. Cloning of full length pri-miR-206 in the livers of SHP
2/2 mice. (a) Hierarchical clustering of the down-regulated miRNAs in the
livers of SHP
2/2 mice compared to wild-type (WT) mice. (b) Schematic of the chromosomal location of the down-regulated miRNAs in SHP
2/2 mice
on chromosome 1. (c) Real-time PCR verification of the miR-206 and miR-133b expression in the livers of WT and SHP
2/2 mice. (d) Schematic of the
genomic structure of miR-206 gene. The gene for miR-206 is located on chromosome 1 on the positive strand. The green arrow represents the
putative transcriptional initiation site (TIS) of pri-miR-206, which is 498 bp upstream of pre-miR-206. The navy arrows indicate the location of 59RACE
primers used to identify TIS. TFs, transcription factor sites. (e) Real-time PCR analysis of pri-miR-206 expression in the livers of WT and SHP
2/2 mice.
Primers are located within the 59RACE amplified region. Data in c and e are represented as mean6SEM. *Significantly different (p,0.01).
doi:10.1371/journal.pone.0006880.g001
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PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e6880Figure 2. Genomic sequences of the miR-206 gene, including the full length sequences of the pri-miR-206 primary transcript and
the miR-206 promoter region. Putative AP1 binding sites are indicated (pink). Primer sequences for RACE (purple), promoter cloning (aqua),
promoter deletion construct (magenta), and ChIP assays (blue): underlined; TIS, transcriptional initiation site; TTS, transcriptional termination site. The
color in word description matches with the color of the gene sequences.
doi:10.1371/journal.pone.0006880.g002
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(Figure 1c). Because this TIS site has not been verified using
additional experimental approaches such as primer extension
assays, we considered this as a putative TIS site. The identification
of this putative TIS allowed us to determine the location of the
miR-206 promoter and to clone it for transcriptional analysis of
miR-206 expression.
YY1 inhibits miR-206 promoter transactivation by AP1
A number of studies have established SHP as a transcriptional
repressor. Thus, the decreased miR-206 expression in SHP
2/2
mice indicated a secondary effect due to the loss of SHP
repression. We hypothesized a ‘‘dual inhibitory mechanism’’, by
which SHP repressed an intermediate gene that inhibited the miR-
206 promoter resulting in a final outcome of SHP activating pri-
miR-206 expression.
The transcription factor activator protein 1 (AP1) is a
heterodimer nuclear protein composed of the proto-oncogene
products c-Jun and c-Fos, and is involved in regulation of cell
proliferation and tumor promotion [14]. AP1 can activate its
target gene promoters through AP1 binding elements. Yin Yang 1
(YY1) is a multifunctional protein that plays a fundamental role in
development, differentiation, replication, and cellular proliferation
[15]. YY1 exerts its effects via its ability to initiate, activate, or
repress transcription depending upon the context of the cells and
promoters. Sequence analysis of the miR-206 promoter with the
MatInspector program predicted four potential binding sites for
AP1 (Figure 2–1, pink). Because it has been reported that YY1 can
inhibit c-Jun activity by direct protein-protein interaction [16], we
investigated whether YY1 could suppress AP1 activity in the miR-
206 promoter.
Overexpression of c-Jun or c-Fos alone showed marginal
activation of the miR-206 promoter, while overexpression of
AP1 containing c-Jun and c-Fos significantly transactivated the
miR-206 promoter in a dose-dependent manner (Figure 3a).
However, this positive regulation was abrogated by YY1 co-
expression (Figure 3b). In contrast, no effect was observed with
SHP alone (not shown) or co-expression on AP1 activity.
Mutagenesis studies by mutating the upstream two AP1 sites
(sites 1&2) in the miR-206 promoter decreased AP1 activity, but
did not abolish it (Figure S2), suggesting that other putative AP1
sites may also contribute to the AP1 responsiveness. Therefore,
three miR-206 promoter luciferase (pro. Luc) reporter deletion
constructs were generated in which putative AP1 sites were
sequentially deleted (Figure 2–1, see primer locations used for
deletion constructs). Transient transfection assays showed that
deletion of AP1 sites 1 and 2 (del 1 pro. Luc) decreased AP1
activity as compared to the normal miR-206 pro. Luc (Figure 3c).
Deletion of AP1 site 3 (del 2 pro. Luc) did not further decrease
AP1 activity, whereas deletion of AP1 site 4 (del 3 pro. Luc)
significantly diminished AP1 activity. Thus, sites 1, 2 and 4 in the
miR-206 promoter appeared to be potent AP1 sites for AP1
activation.
Chromatin immunoprecipitation (ChIP) analysis with a primer
set covering the AP1 sites 1 and 2 confirmed the physical
association of AP1 and YY1 with the endogenous miR-206
Figure 3. YY1 inhibits AP1 activation of the miR-206 promoter and expression. (a) Transient transfection assays to determine AP1 (c-Jun/c-
Fos, 50, 100, 200 ng) transactivation of pri-miR-206 promoter (pro.). The promoter of pri-miR-206 was cloned into a pGL3-basic vector. Hela cells were
transfected with the miR-206Luc in the presence of c-Jun and/or c-Fos plasmids. Luciferase (luc.) activities (act.) were determined, which were
normalized by b-gal (gal.) activities. Con, control (pcDNA3). (b) YY1 (50, 100, 200 ng) inhibition of miR-206Luc activity by AP1 (200 ng). (c) AP1
(200 ng) activation of miR-206Luc deletion constructs (nor, normal promoter containing 4 putative AP1 sites; del 1, AP1 sites 1 and 2 deleted; del 2,
AP1 site 3 deleted; del 3: AP1 site 4 deleted). Con, control (pcDNA3). (d) ChIP assays of c-Jun and YY1 Co-immunoprecipitation (Co-IP) on the miR-206
promoter region containing putative AP1 sites 1 and 2. (e) Real-time PCR analysis of miR-206 expression in Nmuli cells with AP1 and YY1
overexpression. Data in a, b, c, and e are represented as mean6SEM. *Significantly different (p,0.01).
doi:10.1371/journal.pone.0006880.g003
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and YY1 antibodies (Figure 3d). In contrast, a non-specific (n.s.)
primer set located ,11 kb downstream of miR-206 promoter did
not produce PCR product. Nevertheless, overexpression of AP1 (c-
Jun & c-Fos) induced miR-206 expression which was decreased by
YY1 co-expression (Figure 3e). To this point, we conclude that the
miR-206 promoter can be potently transactivated by AP1 and this
response can be reversed by YY1.
SHP inhibits YY1 promoter transactivation by ERRc
We hypothesized that YY1 might be the intermediate gene
through which SHP regulated miR-206 expression. Although the
YY1 promoter had more than 90% GC content and was initially
difficult to amplify, we successfully cloned it into a luciferase
reporter (Figure S3a). ERRc is a nuclear receptor and a target for
SHP repression [3,12]. A conserved estrogen related receptor
response element (ERRE) was identified in the YY1 promoter
(Figure S3b). As predicted, ERRc dramatically activated YY1
promoter, which was repressed by expression of SHP (Figure 4a).
Mutation of the ERRE in the YY1 promoter reduced ERRc
activity below the basal level (Figure 4b). ChIP analysis using
specific ERRc antibodies confirmed ERRc binding to the YY1
promoter in Hepa-1 cells (Figure 4c), in which ERRc showed
increased expression compared to normal mouse hepatocye Nmuli
cells [12]. Finally, the expression of YY1 mRNA was increased by
ERRc and decreased by SHP (Figure 4d). The data identified
ERRc and SHP as novel transcriptional regulators of YY1 gene
expression.
Cascade transcriptional activation of miR-206 by SHP
Based on the above experimental results, we propose a cascade
regulatory model of miR-206 expression. In this model, SHP
inhibits ERRc activation of the YY1 promoter and YY1 represses
AP1 activation of the miR-206 promoter. Thus, SHP inhibition of
ERRc leads to decreased YY1 expression and the de-repression of
YY1 on AP1 activity, which ultimately leads to the increase in
miR-206 expression (Figure 5a). In support of this model, the
expression of YY1 and ERRc was increased whereas the
expression of c-Jun was decreased in livers of SHP
2/2 mice
(Figure 5b), which corresponded to the down-regulation of miR-
206 (Figure 1).
We further tested the effect of each individual nuclear receptor
and transcription factor on miR-206 expression in Nmuli cells. As
expected, SHP overexpression resulted in an induction of miR-206
expression (Figure 5c–a’). Unfortunately, we could not obtain
satisfactory results with SHPRNAi due to the low SHP levels and
knockdown efficiency in Nmuli cells. Expression of ERRc caused a
reduction of miR-206 levels, which was reversed in ERRc-siRNA
transfected cells (Figure 5c–b’). In a similar way, an inhibitory
effect of miR-206 was observed in YY1 overexpressed cells and the
repression was absent when YY1 levels were decreased by siRNA
(Figure 5c–c’). Consistent with the previous results, AP1 (c-Jun &
c-Fos) induced miR-206 expression and the effect was partially
blocked by c-Jun knockdown (Figure 5c–d’). Considering together,
these results demonstrate a cascade regulatory mechanism
governing miR-206 gene transcription which involved SHP,
ERRc, YY1, and AP1.
Discussion
MiR-206 was initially identified as a skeletal muscle specific
miRNA [17] that played an important function in muscle
development [18–20]. Recent studies showed that miR-206 was
downregulated in estrogen receptor (ER) positive breast cancer
[21], which may be associated with ER as a miR-206 target [22].
Thus, miR-206 is suggested to function as a suppressor of breast
cancer metastasis [23], although the mechanism remains to be
defined. In addition, the expression of miR-206 in the brain has
been associated with schizophrenia [24]. Recently, specific
expression of miR-206 was reported in brown adipocytes [25]
and the expression level of miR-206 was also increased in bone
marrow-derived DC19
+ WM cells associated with Waldenstrom
macroglobulinemia [26]. Although miR-206 is less abundant in
the liver, our study identified down-regulation of miR-206 in the
liver of SHP
2/2 mice. These observations suggest a broader tissue
specific expression and physiological function of miR-206 than
originally anticipated.
Despite the important function of miR-206 in physiological
regulation, how the expression of miR-206 is controlled at the
transcriptional level remains unknown. To address this question,
we first cloned the full length pri-miR-206 using a bioinformatics
approach. Cloning of pri-miR-206 is significant, because only a
few miRNAs have their full length primary sequences determined
[11,27,28]. It is noted that the identified transcriptional initiation
site of pri-miR-206 is localized in a simple GGA/GAA sequence
repeat region, with no identifiable core promoter elements.
However, this feature is not unusual for the miRNA genes. Our
previous studies identified (CT)n or (CTT)n simple sequence
repeats in the promoter of the primary transcript of miR-127
[11,12]. Another study also showed that TATA-box was not
Figure 4. SHP inhibits ERRc activation of YY1 promoter and expression. (a) SHP repression of YY1 promoter transactivation by ERRc.
Transient transfection assays to determine ERRc (20, 40, 80 ng) transactivation and SHP (100, 200, 400 ng) transrepression of YY1 promoter (pro.).
(b) Mutagenesis assays. The ERRE of the YY1 promoter Luc was mutated and used for transient transfection. (c) ChIP assays of ERRc Co-
immunoprecipitation (Co-IP) on the YY1 promoter region containing a putative ERRE. (d) Real-time PCR analysis of YY1 mRNA expression in Nmuli
cells with ERRc and SHP overexpression. Data in a, b, and d are represented as mean6SEM. *Significantly different (p,0.01).
doi:10.1371/journal.pone.0006880.g004
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although most studied miRNA genes of A. thaliana and O. sativa
contained TATA-box [29]. In addition, several other studies
reported that (CT)n, (CCT)n, (CTT)n, (CCTT)n, (CGCT)n,
(CCTCG)n, (CCTCT)n, (CGTCT)n, and (CTCTT)n simple
sequence repeats were the significant motifs in core promoters of
miRNA Genes [30–33].
A major funding of this study is the identification of a cascade
regulatory mechanism governing miR-206 expression by SHP.
Genes encoding miRNAs are transcribed by RNA polymerase II
[27] and in some cases RNA polymerase III [34]. However, little is
known about how transcriptional regulation affects miRNAs levels
and function in cells and tissues. Using both an in vitro cell system
and in vivo gene expression analysis, we show that several nuclear
transcription factors and signaling molecules, including SHP,
ERRc, YY1, and AP1, coordinately regulate the transcription of
miR-206. Thus, SHP is identified as a transcriptional activator of
miR-206 expression via a ‘‘dual inhibitory’’ mechanism. Because
the expression of miR-206 is also markedly down-regulated in
skeletal muscle of SHP
2/2 mice compared to the wild-type mice
(Figure S4), where it is preferentially expressed, we propose that
this transcriptional cascade that activates miR-206 by SHP may
exist in muscle as well. The data suggests that complexity mRNA-
miRNA interactions participate in miR-206 control of multiple
cellular processes.
Methods
Total RNA isolation and miRNA microarray analysis
Protocols for animal use were approved by the Institutional
Animal Care and Use Committee at the University of Utah. Total
RNA with miRNA was isolated from the liver of two month old
male mice (n=3) using mirVana
TM miRNA Isolation Kit
(Ambion, Austin, TX). The RNA quality control was performed
using Bioanalyzer 2100. SHP knockouts (SHP
2/2) and wild type
mice on a pure C57/BL6 background were analyzed. The mice
were given normal chow diet under feeding conditions. MiRNA
microarray including labeling, hybridization, image scanning and
Figure 5. A ‘‘dual-inhibitory’’ mechanism activating miR-206 gene transcription by SHP. (a) Proposed cascade regulatory model
activating miR-206 expression by SHP. (b) Real-time PCR analysis of ERRc and YY1 mRNA expression and semi-quantitative PCR analysis of c-Jun
mRNA expression in the livers of SHP
2/2 and wild-type (WT) mice. (c) Top: real-time PCR analysis of miR-206 expression in Nmuli cells with SHP (a’),
ERRc (b’), YY1 (c’) and AP1 (d’) overexpression or knockdown. Bottom: semi-quantitative PCR analysis of ERRc (left), YY1 (middle), and c-Jun (right)
expression level in cells transfected with a control (con) or gene specific shRNA against ERRc, YY1, and c-Jun, respectively. Data in b and c are
represented as mean6SEM. *Significantly different (p,0.01).
doi:10.1371/journal.pone.0006880.g005
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LCsciences.com, Houston, TX). All protocols were deposited at
ArrayExpress. LC-miRHumanMouseRat-9.1-070207-MRA-1030
array was used which was deposited in MIAMExpress. In brief,
arrays were made based on mParaflo microfluidic technology
(Atactic Technologies). On the mParaflo microfluidic chip, each
detection probe consisted of a chemically modified nucleotide
coding segment complementary to target microRNA (from
miRBase, http://microrna.sanger.ac.uk/sequences/) or other
RNA (control or customer defined sequences) and a spacer
segment of polyethylene glycol to extend the coding segment away
from the substrate. The detection probes were made by in situ
synthesis using photogenerated reagent (PGR) chemistry (Array
Protocol: LC Mir-Array-Prtl-060518). Small RNAs (,300 nt)
were 39-extended with a poly(A) tail using poly(A) polymerase. An
oligonucleotide tag was then ligated to the poly(A) tail for later
fluorescent dye staining; two different tags were used for the two
RNA samples in dual-sample experiments (Labeling Protocol: LC
Mir-Label Prtl-060518). Hybridization was performed using a
micro-circulation pump (Atactic Technologies). The hybridization
conditions were 100 mL 6xSSPE buffer (0.90 M NaCl, 60 mM
Na2HPO4, 6 mM EDTA, pH 6.8) containing 25% formamide,
34uC, and overnight (Hybridization Protocol: LC Mir-Hyb Prtl-
060518). Hybridization images were collected using a laser
scanner (GenePix 4000B, Molecular Device). Scan resolution
was set at 10 m and PTM is set between 350 to 700 V (Scanning
Protocol: LC Mir-Scan Prtl-060518). Data were analyzed by first
subtracting the background and then normalization. The
background was determined using a regression-based background
mapping method. The regression was performed on 5% to 25% of
the lowest intensity data points excluding blank spots. Raw data
matrix was then subtracted by the background matrix. Normal-
ization was carried out using a LOWESS (Locally-weighted
Regression) method on the background-subtracted data (Normal-
ization Protocol: LC Mir-Norm Prtl-060518). The data was
deposited to the ArrayExpress database and the accession number
is E-MEXP-1721 [12].
Database mining and EST extension
MiRNAs precursor sequences were downloaded from the
Sanger Institute (http://microrna.sanger.ac.uk/ sequences). The
BLASTN search of the mouse genome was done online. The
mouse EST and ncRNA database were downloaded from
GenBank. A 3 kb genomic sequence centered in the miRNA
precursor was extracted manually and used as query to search the
EST and ncRNA database with the command ‘‘Megablast -e 1e-
100 -F ‘‘m L’’ -D 3’’. The Blast Packages (v2.2.10) were
downloaded from the NCBI website (ftp://ftp.ncbi.nlm.nih.gov.
blast/executables). The ncRNA and ESTs with the opposite
transcription direction compared to query were removed from the
Blast hits. The hits with an aligned length less than 95 of their
original length were filtered out. After filtering, the ESTs matched
to the 22 kb to 2 kb flanking regions were selected for further
analysis [11].
Real-time RT-PCR quantification of miRNAs
Real-time reverse transcription polymerase chain reaction (RT-
PCR) quantification of miRNA expression was carried out using
TaqManH MicroRNA Assays Kit (Applied Biosystems Inc. Foster
City, CA) according to manufacturer’s protocol. snoRNA202 was
used as an internal control to normalize RNA input in the real-
time RT-PCR assay. The detailed method was described in our
recent publication [12].
RACE mapping of miRNA primary transcript
Total liver RNA was isolated using an RNeasy Mini Kit
(Qiagen, Valencia, CA) and mRNA was isolated using an Oligotex
Direct mRNA Mini Kit (Qiagen, Valencia, CA). The GeneRacer
Kit (Invitrogen, California, USA) was used to map the
transcriptional initiation site of primary transcript. The first strand
cDNA was synthesized at 65uC with Thermo-X
TM reverse
transcriptase using 2 mg of mRNA, followed by a polymerase
chain reaction with 95uC denaturation step and then 45 cycles of
touchdown annealing temperature. Primer sequences are indicat-
ed in Figure 2. The genomic sequences of the miR-206 gene was
deposited in GenBank, Accession number FJ469647.
Transient transfection and luciferase assay
Expression plasmids of SHP, ERRc, YY1, c-Jun, and c-Fos
were cloned into the pcDNA3 vector. Luciferase reporters of miR-
206 and YY1 were cloned into the pGL3 reporter construct
(Promega, Madison, WI). Twenty four hours before transfection,
5610
4 cells were plated per well in a 24-well plate. 30 ng of miR-
206 or YY1 luciferase reporter construct, different concentrations
of expression plasmid, and 30 ng of beta-gal plasmid pSV-b-
Galactosidase Control Vector (Promega, Madison, WI) were
transfected using FuGENE HD (Roche, Indianapolis, IN).
Different amounts of expression vector pcDNA3 were added to
keep the final amount of DNA constant for all transfections. Thirty
six hours after transfection, luciferase and b-galactosidase assays
were performed using the Luciferase Assay System system and
Beta-GloH Assay System (Promega, Madison, WI). Luciferase
activities were normalized to galactosidase activities for each
transfected well. For each experimental trial, wells were transfect-
ed in triplicate and each well was assayed in triplicate.
Chromatin immunoprecipitation (ChIP) assays
ChIP Assays were performed using the ChIP Assay Kit (Upstate
Biotechnology, Lake Placid, NY). Hepa-1 cells were cultured until
70%–80% confluence. Chromatin was cross-linked with 1%
formaldehyde at 37uC for 10 min. Cells were washed with cold
PBS twice and disrupted in SDS Lysis Buffer containing the
protein inhibitor cocktail. Chromatin was sonicated to shear DNA
to an average length between 200 bp and 1000 bp as verified by
agarose gel. The sonicated cell supernatants were diluted 10 fold in
ChIP Dilution Buffer containing the protein inhibitor cocktail and
an aliquot of the solution was reserved for input control. Ten
micrograms of YY1 (Abcam, Cambridge, MA), ERRc (Aviva
Systems Biology, San Diego, CA), or c-Jun (Abcam, Cambridge,
MA) antibodies were added and the chromatin solution was gently
rotated overnight on ice. The protein A agarose slurry was added
to the antibody bound chromatin solution and incubated at 4uC
for 1 hr with constant rotation. The agarose beads were collected
by centrifugation, washed and the antibody bound chromatin was
released from the agarose beads. Finally, the DNA was purified by
phenol/chloroform extraction and ethanol precipitation. The
binding region was detected using primers in PCR reactions. A
10 kb region downstream from the binding site was used as
negative control (n.s.). All ChIP primers used for miR-206
promoter and YY1 promoter are indicated in Figure 2-1 and
Figure S2b. The non-specific primers for miR-206 promoter ChIP
assays are: F: 59-CTACTTATGCAGCTAGAGATACAAG-39
and R: 59-ACTTCCAATAAGTCTTTGACCCATG-39.
RNA interference (RNAi)
ShRNA constructs against Mus musculus ERRc, SHP, YY1 and
c-Jun were purchased from Origene Company (Rockville, MD).
SHP Activates miR-206
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constructs were transfected into the cells using transfection reagent
Fugene HD (Roche) according to the manufacturer’s instructions.
The level of miR-206 expression was determined using real-time
PCR.
Statistical analysis
All the experiments were repeated at least three times and the
error bars represent the standard error of the mean (SEM).
Statistical analyses were carried out using Student’s unpaired t test;
p,0.01 was considered statistically significant.
Supporting Information
Table S1 MiRNAs with the largest magnitude of down-
regulation in SHP2/2 mice. miR-206 and miR-133b were
clustered on chromosome 1, whereas miR-1 and miR-133a were
clustered on chromosome 2. The expression level of miR-206 was
markedly higher than miR-133b, and the expression level of miR-
1 was markedly higher than miR-133b.
Found at: doi:10.1371/journal.pone.0006880.s001 (1.30 MB TIF)
Table S2 Down-regulated miRNAs in SHP2/2 mice on
chromosome 1.
Found at: doi:10.1371/journal.pone.0006880.s002 (1.30 MB TIF)
Figure S1 (a) Determining the putative transcriptional initiation
site (TIS) by 59-RACE for pri-miR-206. Total liver RNA was
isolated using RNeasy Mini Kit (Qiagen, Valencia CA) and
mRNA was isolated using a Oligotex Direct mRNA Mini Kit
(Qiagen, Valencia CA). A GeneRacer Kit (Invitrogen, California
USA) was used to map the transcriptional initiation site of the
primary transcript. (b) Chromatogram of 59 RACE sequences of
the pri-miR-206 primary transcript. The putative transcriptional
initiation site of pri-miR-206 (G) is indicated by a pink arrow.
Found at: doi:10.1371/journal.pone.0006880.s003 (3.89 MB TIF)
Figure S2 Mutagenesis assays. Two upstream putative AP1 sites
(sites 1&2) (see Figure 2–1 for the location of each site) of the miR-
206 promoter was mutated by using the QuickChange XL site-
Directed Mutagenesis Kit (Stratagene), which generated the
mutated miR-206 promoter luciferase reporter mut1 (single AP1
site 1 mutation) and mut1-2 (double AP1 sites 1&2 mutation). For
luciferase reporter experiments, 30 ng of wt, mut1, mut1-2 and
30 ng of b-gal plasmid pSV-b-Galactosidase control vector were
co-transfected with the AP1 expression vector (80 ng) into Hela
cells using FuGENE HD (Roche). Thirty six hours after
transfection, luciferase and b-galactosidase assays were performed
using the Luciferase Assay System system and Beta-GloH Assay
System (Promega). Luciferase activities were normalized to
galactosidase activities for each transfected well. For each
experiment, wells were transfected in triplicate and each well
was assayed in triplicate.
Found at: doi:10.1371/journal.pone.0006880.s004 (3.89 MB TIF)
Figure S3 (a) Cloning of the high GC content mouse YY1
promoter. The PCR product was cloned into a pGL3-basic vector
and used for transfection assays. The construct was verified by
sequencing. (b) YY1 promoter sequences. TSS, transcriptional
start site; ERRE, putative ERR binding site; YY1 pro. F and R,
forward and reverse primers used to clone the YY1 promoter
(pro.) and for ChIP assays.
Found at: doi:10.1371/journal.pone.0006880.s005 (3.89 MB TIF)
Figure S4 Real-time PCR analysis of miR-206 expression in
skeletal muscle of SHP2/2 and SHP+/+ mice. Data is
represented as mean6SEM. *Significantly different (p,0.01).
Found at: doi:10.1371/journal.pone.0006880.s006 (3.89 MB TIF)
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